Neurovision Medical Products, a US-based manufacturer of neuromonitoring technologies, has announced that it has been granted two new US patents for its Cobra endotracheal tube electrode.
The company has designed the Cobra endotracheal tube electrode for providing minimal disruption to anesthesiology, while optimizing relevant data acquisition from the patient.
Neurovision Medical Products president and CEO Dr James Lee Rea noted the company’s goal is to provide functional and clinical benefits in the products that it designs.
"This product line offers the clinician the state of the art in recurrent laryngeal neuromonitoring," Dr Rea added.
Neurovision Medical Products’ mission is to create and manufacture differentiated neuromonitoring device solutions that have the ability to provide safer procedural outcomes.